Stroke in the Elderly

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

The growing number of older people is at high risk of stroke. Stroke incidence rises with increasing age and in the very old. Several studies have suggested geographical disparities and regional differences. Several studies have shown different risk profiles between the elderly and younger patients. About 50% of the ischaemic strokes are due to atherosclerosis in the large arteries and may follow hypoperfusion or atherogenic embolism. Small vessel disease giving rise to lacunar infarcts amounts to 25%. A further 25% are due to cardiac embolism and the remaining to a number of causes, namely, cryptogenic, arteritis and dissection among others. This chapter reviews the epidemiology and pathophysiology of stroke, its clinical expression diagnosis and management.

Keywords

Stroke Atherosclerosis Embolism Cerebral infarction Cerebral haemorrhage 

References

  1. 1.
    Di Carlo A, Launer LJ, Breteler MMB, Breteler MM, Fratiglioni L, Lobo A, et al. Frequency of stroke in Europe: A collaborative study of population based cohorts. ILSA working Group and the Neurological Diseases in the Elderly Research Group: Italian Longitudinal Study on Ageing. Neurology. 2000; 54(11 Suppl 5): S34–7.Google Scholar
  2. 2.
    Sabayan B, Gussekloo J, de Ruijter W, Westendorp RGJ, de Craen JM. Framingham Stroke Risk Score and Cognitive impairment for predicting first-time stroke in the oldest old. Stroke. 2013;44:1866–1871.PubMedCrossRefGoogle Scholar
  3. 3.
    Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence risk case fatality of first ever stroke in the elderly population: the Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74:317–321.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Bots M, Looman S, Koudstaal PJ, Hofman A, Hoes A, Grobbee DE. Prevalence of stroke in the general population: the Rotterdam Study. Stroke. 1993;138:101–106.Google Scholar
  5. 5.
    Liebetrau M, Steen B, Skog I Stroke in 85 year olds: Prevalence, incidence, risk factors and relation to mortality and dementia. Stroke. 2003;34:2617–2622.PubMedCrossRefGoogle Scholar
  6. 6.
    Bramford J, Sandercock P, Dennis M, Burns J, Warlow C, Gray M. A prospective study of acute cerebrovascular disease in the community, the Oxfordshire Community Stroke Project 1981-86-1: methodology, demography and incidence increase of first ever stroke. J Neurol Neurosurg Psychiatry. 1988;51:1373–1380.CrossRefGoogle Scholar
  7. 7.
    Brown RD, Whisnsant JP, Sicks D, O’Fallon WM, Wiebero DO. Stroke incidence, prevalence and survival: recent trends in Rochester Minnesota through 1989. Stroke. 1996; 27: 373–380.PubMedGoogle Scholar
  8. 8.
    Gur AY, Tanne D, Bornsten NM, Milo R, Auriel E, Shopin L, et al. Stroke in the very elderly: characteristics and outcome in patients aged >85 years with a first ever ischaemic stroke. Neuroepidemiology. 2012;39:57–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Rich DQ, Gaziano JM, Kurth T. Geographical patterns in overall and specific cardiovascular disease in apparent healthy men in the United States. Stroke. 2007;38:3221–3222.CrossRefGoogle Scholar
  10. 10.
    Li SC, Schoenberg BS, Wang C, Cheng XM, Bolis CL, Wang KJ. Cerebrovascular disease in the People’s Republic of China: epidemiologic and clinical features. Neurology. 1985; 35: 1708–13.PubMedCrossRefGoogle Scholar
  11. 11.
    WHO Stroke 1989 Recommendations on stroke prevention, diagnosis and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989; 20: 1407–1431.CrossRefGoogle Scholar
  12. 12.
    American Heart Association, 2001 Heart and Stroke Statistical Update, Dallas, Texas: Amer Heart Assoc. 2000.Google Scholar
  13. 13.
    Steiner T, Bosel J Options to restrict haematoma expansion after spontaneous intracerebral haemorrhage. Stroke. 2010; 41: 402–409.PubMedCrossRefGoogle Scholar
  14. 14.
    Agarwal SK, Heiss G, Ratuaharju PM, Shahar E, Massing MM, Simpson RJ Jr. Premature ventricular complexes and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 2010; 41: 588–593.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Hart CL, Hole DJ, Smith GD. The contribution of risk factors to stroke differentials by socioeconomic poor in adulthood. The Renfren/Parsley Study. Am J Public Health. 2000; 90(11): 1788–1791.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Avendano M, Kawachi I, Van Lenthe F, Boshuizen HC, Mackenbach JP, Van de Bos GA, et al. Socioeconomic status and stroke incidence in the US elderly. Stroke. 2006; 37: 1368–1373.PubMedCrossRefGoogle Scholar
  17. 17.
    Cesaroni G, Agabiti N, Forastiere F, Perucci CA. Socioeconomic differences and stroke incidence and prognosis under a universal health care system. Stroke. 2009; 40(8): 2812–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Bongers T, de Maat M PM, van Goor M-L PJ, Bhagwanbalai V, van Vliet HHDM, Garcia EBG, et al. High von Willebrand Factor levels increase the risk of first ischaemic stroke. Influence of ADAMTS13. inflammation and genetic variability Stroke. 2006; 37(11): 2672–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Sato M, Suzuki A, Nagata K, Uchiyama S. Increased von Willebrand Factor in acute stroke patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2006; 5(1): 1–7.CrossRefGoogle Scholar
  20. 20.
    Sarti C, Rastenyte D, Cepaitis Z, Tuomilento J. International trends in mortality from stroke. 1968-1994 Stroke. 2000;31:1588–1601.PubMedCrossRefGoogle Scholar
  21. 21.
    Chen Y-M, Lin Y-J, Po HL. Comparison of the risk factor profile, stroke subtypes and outcome between stroke patients aged 65 teats or younger and elderly stroke patients: A hospital based study. Int H Gerontol.  https://doi.org/10.10016/ijge.2012.11.01.
  22. 22.
    Shimizu H, Kawarai T, Saji N, Tadano M, Kita Y, Tabuchi M, et al. Re-evaluation of clinical features and risk factors of acute ischaemic stroke in Japanese longevity society. Kobe J Med Sci. 2009;55(6):E13-E139.Google Scholar
  23. 23.
    Lewington S, Clarje R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Weverling-Rijnsburger A, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. High density vs low density lipoprotein cholesterol as the risk factors for coronary artery disease and stroke in old age. Arch Intern Med. 2003;103(3):1549–54.CrossRefGoogle Scholar
  25. 25.
    Auriel E, Gur AY, Uralev O, Brill S, Shopin L, Karni A, et al. Characteristics of first ever ischaemic stroke in the very elderly: Profile of vascular risk factors and clinical outcome. Clin Neurol Neurosurg. 2011.  https://doi.org/10.1016/jclineuro.2011.05.4.
  26. 26.
    Saposnick G, Cote R, Phillips S, Gubitz G, Bayer N, Minuck J, et al. Stroke outcome in those over 80. Stroke. 2008;39:2310–12317.CrossRefGoogle Scholar
  27. 27.
    Kammersgaard LP, Jorgensen HS, Reith J, Nakeyama H, Pedersen HS, Olsen TS. Short and long term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Aging. 2004;33:149–154.Google Scholar
  28. 28.
    Ostfeld AM. A review of stroke epidemiology. In PE Sartwell and N Nathanson, eds Epidemiologic Reviews vol 2. Baltimore. The Johns Hopkins University Press. 1980; p 136–152.Google Scholar
  29. 29.
    Kannel WB, Wolf IA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framinghm Study. JAMA. 1970;214:301–310.PubMedCrossRefGoogle Scholar
  30. 30.
    Salonen JT, Puskin P, Tuomilheto J, Howan K. Relation of blood pressure, serum lipids and cigarette smoking to the risk of cerebral stroke. Stroke. 1982;13:327–333.PubMedCrossRefGoogle Scholar
  31. 31.
    Kuller L, Seltser R. Cerebrovascular disease mortality in Maryland. Am J Epidemiol. 1967;86:42–449.CrossRefGoogle Scholar
  32. 32.
    Morte DD, Abete P, Gallucci F, Scaglione A, D’Ambrosio D, Garguilo G, et al. Transient ischaemic attack before nonlacunar ischaemic stroke in the elderly. J Stroke Cardiovasc Dis. 2008;17(5):257–262.CrossRefGoogle Scholar
  33. 33.
    Bowen KK, Naylor M, Vemuganti R. Prevention of inflammation is a mechanism of pre-conditioning-induced neuroprotective against focal cerebral ischaemia. Neurochen Int. 2006;49(2):127–36.CrossRefGoogle Scholar
  34. 34.
    Tuttolomondo A, Di Sciacca R, Raimondo D, Renda C, pinto A, Licata G. Inflammation as a therapeutic target in acute ischaemic stroke treatment. Curr Top Clin Chem. 2009;9(14):1240–60.CrossRefGoogle Scholar
  35. 35.
    Murtagh B, Smalling RW. Cardioembolic stroke. Curr Atherosclr Rep. 2006;8:310–6.CrossRefGoogle Scholar
  36. 36.
    Ferro JM. Brain embolism. Answers to practical questions. J Neurol. 2003;250:139–141.PubMedCrossRefGoogle Scholar
  37. 37.
    DiTullio MR, Homma S,. Mechanisms of cardioemboli stroke. Curr Cardiol Rep. 2002;4:141–8.CrossRefGoogle Scholar
  38. 38.
    Arboix A, Alio J. Cardioembolic stroke: clinical features, specific cardiac disorders and progress. Curr Cardio Rev. 2010;6:150–161.CrossRefGoogle Scholar
  39. 39.
    Garcia JH, Andersen ML. Circulatory disorders and their effects on the brain. pp 715–822. In Davis RL, Roberston DM (eds): Textbook of Neuropathology, 3rd edition. William &Wilkins, Baltimore, 1997.Google Scholar
  40. 40.
    Mangla R, Kolar B, Almast J, Ekholm SE. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011;31(5):1201–14.PubMedCrossRefGoogle Scholar
  41. 41.
    Klatzo I. Presidential address. Neuropathological aspects of brain oedema. J Neuropathol Exp Neurol. 1967;26:1–14PubMedCrossRefGoogle Scholar
  42. 42.
    Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6(3):258–268.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Gasche Y, Copin C. Blood brain barrier pathophysiology and ischaemic brain oedema. Ann Fr Anesth Reanim. 2003;22(4):312–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Zador Z, Stiver S, Wang V, Manley GT. Role of aquaporin-4 in cerebral edema and stroke. Handb Exp Pharmacol. 2009;(190):159–170.CrossRefGoogle Scholar
  45. 45.
    Katzman R, Clasen R, Klatzo I, Meyer JS, Pappus HM, Waltz AG. Brain Oedema in stroke. Study group on brain edema in stroke. http://stroke.ahajournals.org/. Accessed on 25 April, 2016.
  46. 46.
    Sutherland GR, Auer RN. Primary intracerebral haemorrhage. J Clin Neurosci. 2006;13:511–17.PubMedCrossRefGoogle Scholar
  47. 47.
    Bamford J, Sandercock B, Dennis M, Burns J, Warlow C. A prospective study of acute cardiovascular disease in the community: the Oxfordshire community Stroke Program:1981–1987. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 190;53:162–22.Google Scholar
  48. 48.
    Broderick JP, Brott T, Tomsick T, Huski G, Miller R. The rise of subarachnoid and intracerebral haemorrhages in blacks as compared to whites. NEJM. 1992;326:733–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Sahini R, Weinberger J. Management of intracerebral haemorrhage. Vasc Health Risk Manag 2007;3(5):701–709.Google Scholar
  50. 50.
    Ott BR, Zamani A, Kleefield J, Funkenstein HH. The clinical spectrum of haemorrhagic infarct. Stroke. 1986;17:630–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy; incidence and complications in the aging brain The distribution of amyloid vascular changes. Stroke. 1983;14:924–928.PubMedCrossRefGoogle Scholar
  52. 52.
    Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol. 1987;234371–376.Google Scholar
  53. 53.
    Ritter MA, Droste DW, Hegedus, Szepesi R, Csiba L, Ringelstein EB, et al. Role of cerebral amyloid angiopathy in intracerebral haemorrhage in hypertensive patients. Neurology. 2005; 64:1233–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Norriving B. Lacunar infarcts. Ther Umsch. 2003;60(9):535–40.CrossRefGoogle Scholar
  55. 55.
    Kapelle LJ, van Gjn J. Lacunar infarction. Clin Neurol Neurosurg.1986;88:3–17.CrossRefGoogle Scholar
  56. 56.
    Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TK, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Arch Neurol. 1989;25:382–390.Google Scholar
  57. 57.
    Dombovy ML. Stroke: Clinical course and neurophysiologic mechanisms of recovery. Critical reviews: Physical and Rehab Med. 1991;2(27):171–188.Google Scholar
  58. 58.
    Kim JS. Pure sensory stroke: Clinical-radiological correlates of 21 cases. Stroke. 1992;23:983–987.PubMedCrossRefGoogle Scholar
  59. 59.
    Arboix A, Garcia-Plata C, Garcia-Eroles L, Massns J, Comes E, Oliveres M, et al. Clinical study of 99 patients with pure sensory stroke. J Neurol. 2005;252(2):156–62.PubMedCrossRefGoogle Scholar
  60. 60.
    Nagaratnam N, Xavier C, Fabian R. Stroke-subtype- ataxic hemiparesis. Neurorehab Neurol Repair. 1999: 13: 67–71.Google Scholar
  61. 61.
    Arboix A, Bell Y, Garcia-Eroles L, Massons J, Comes E, Balcells M, et al. Clinical study of 35 patients with dysarthria-clumsy hand syndrome. J Neurol Neurosurg Psychiatry. 2004;75(2):231.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Ionita C. Lacunar infarction. Clinical presentation.www.medmerits.com/index-php/article/lacunar_infarction/P2.
  63. 63.
    Murtagh B, Smalling RW. Cardioembolic stroke. Curr Atherosclr Rep. 2000;8:310–6.CrossRefGoogle Scholar
  64. 64.
    Ferro JM. Cardioembolic stroke: an update. Lancet Neurol. 2003;2:177–88.PubMedCrossRefGoogle Scholar
  65. 65.
    Di Tullio MR, Homma S. Mechanisms of cardioembolic stroke. Curr Cardio Rep. 2002;4:141–8.CrossRefGoogle Scholar
  66. 66.
    Gacs G, Fox AJ, Burnett HJM, Vinuella F. Occurrence and mechanisms of occlusion of the anterior cerebral artery. Stroke. 1993; 14: 952–959.CrossRefGoogle Scholar
  67. 67.
    Kazui S, Sawada T, Naritomi H, Kuriyama Y, Yamaguchi T. Angiographic evolution of brain infarction limited to the anterior cerebral artery territory. Stroke. 1993;24:549–553.PubMedCrossRefGoogle Scholar
  68. 68.
    Kumral E, Bayulkem G, Evyapan D, Yunten N. Spectrum of anterior cerebral artery infarction: clinical and MRI findings. Eur J Neurol. 2002;9(6):615–24PubMedCrossRefGoogle Scholar
  69. 69.
    Abroix A, Garcia-Eroles I, Seallares N, Raga A, Oliveres M, Massons J. Infarction in the territory of the anterior cerebral artery : Clinical study of 51 patients. BMC Neurol. 2009;9:30.CrossRefGoogle Scholar
  70. 70.
    Takahashi S, Fukasawa H, Ishii K, Sakamoto K. The anterior choroidal artery syndrome. Neuroradiology. 1994;36(5): 337–339.PubMedCrossRefGoogle Scholar
  71. 71.
    Leys D, Mounier-Vehier F, Lavenu I, Rondepiere Ph, Provo JP. Anterior choroidal territory infarcts: study of presumed mechanism. Stroke. 1994;25:837–842.PubMedCrossRefGoogle Scholar
  72. 72.
    Decroix JP, Gravelean PH, Masson M, Gambier J. Anterior choroidal artery syndrome. Brain. 1986;109(6):1071–1085.PubMedCrossRefGoogle Scholar
  73. 73.
    Steegmann AT, Roberts AJ. The syndrome of anterior choroidal artery. J Amer Assoc. 1935;104:1695–1697.CrossRefGoogle Scholar
  74. 74.
    Mohr JP, Watters WC, Duncan GW. Thalamic haemorrhage and aphasia. Brain Lang. 1975; 2: 3–17.PubMedCrossRefGoogle Scholar
  75. 75.
    Derex L, Ostrowsky K, Nighoghossian N, Tronillas P. Severe pathological crying after left anterior choroidal artery infarct-reversibility with paroxetine treatment. Stroke. 1997; 28: 1464–1466.PubMedCrossRefGoogle Scholar
  76. 76.
    Nagaratnam N, Wong V, Jeyaratnam D. Left anterior choroidal artery infarction and uncontrollable crying. J Stroke Cerebrovasc Dis. 1998;7(4): 263–264PubMedCrossRefGoogle Scholar
  77. 77.
    Weerakoddy Y, D’Souza, et al. Recurrent artery of Heubner. http://radiopaedia.org/articles/recurrent-artery-of heubner-1 retrieved 20.7.11.
  78. 78.
    Slater DI, Curtin SA, Johns JS, Schmidt C. Middle cerebral artery stroke. E Medicine Physical Medicine and Rehabilitation. 2009. http://emedicine.medscape.com/article/323120overview. Accessed 8 April 2010.
  79. 79.
    Barnett H, Mihr JP, Stein B, Yatsu F. Stroke: Pathogenesis, diagnosis and management. 2nd ed London, England. Churchill Livingstone.1992:360–405.Google Scholar
  80. 80.
    Sinanovic O, Mrkonjic Z, Zukic S, Vidovic M, Imamovic K. Postlanguage disorders. Acta Clin Croat. 2011;50(1):79–94.PubMedGoogle Scholar
  81. 81.
    Jung S, Hwang S-H, Lee B-C. Distinct clinical expressions of striatocapsular infarction according to cortical manifestations. Eur J Neurol. 2004;11(9): 627–633.PubMedCrossRefGoogle Scholar
  82. 82.
    Momjian-Meyer I, Baron J-C. The pathophysiology of watershed infarction in internal carotid artery disease. Stroke. 2005; 36: 567–577.CrossRefGoogle Scholar
  83. 83.
    Ringelstein ED, Zenner H, Angelou D. The pathogenesis of strokes from internal carotid artery occlusion: diagnostic and therapeutic implications. Stroke. 1983;14:876–875.CrossRefGoogle Scholar
  84. 84.
    Bogousslavsky J, Regli F. Border zone infarctions distal to the internal carotid artery occlusion.: prognostic implications. Ann Neurol. 1986; 20: 346–350.PubMedCrossRefGoogle Scholar
  85. 85.
    Ghika JA, Bogousslavsky J, Regli F. Deep perforators from the carotid system. Arch Neurol 1990;47:1097–1100.PubMedCrossRefGoogle Scholar
  86. 86.
    Angelino O, Bozzao L, Fantozzi L, Bastianello S, Kushner M, Fieschi C. Internal border zone infarction flowing acute middle cerebral artery occlusion. Neurology. 1990;40:1196–1198.CrossRefGoogle Scholar
  87. 87.
    Bladin CF, Chambers BR. Clinical features pathogenesis and computed tomographic characteristics of internal water shed infarctions. Stroke. 1993;24:1925–1932.PubMedCrossRefGoogle Scholar
  88. 88.
    Millandre L, Brosset C, Botti, Khalil A study of 82 cerebral infarction in the area of the posterior cerebral arteries. Rev Neurologique. 1994;150:133–41.Google Scholar
  89. 89.
    Monet P, Garcia PY, Salion G, Spagnolo S, Desblache J, Franc J, et al. Bithalamic infarct. Is there an evocative aspect? Radioclinical study. Rev Neurol (Paris). 2009;165:178–184.PubMedCrossRefGoogle Scholar
  90. 90.
    Neau JP, Bogousslasky J. The syndrome of posterior choroidal artery territory infarction. Ann Neurol. 1996;39:779–188.PubMedCrossRefGoogle Scholar
  91. 91.
    Milsavljevic M, Marinkovic S, Gibo H, Puskas L. The thalamogeniculate perforators of the posterior cerebral artery: The microsurgical anatomy. Neurosurgery. 1991;28:523–530.CrossRefGoogle Scholar
  92. 92.
    Lee HM, Lee BC, Kang KS, et al. Clinical manifestations of thalamogeniculate artery territory infarction. 1996. http://bbs.neuro.ovkr/space/journal/1990/9602003.pdf. accessed 12/04/2010.
  93. 93.
    Fisher CM. Lacunar infarct of the tegmentum of the lower lateral pons. Arch Neurol. 1984; 46(8): 566–567.Google Scholar
  94. 94.
    Amarenco R. Hauw JJ. Cerebellar infarction in the territory of the anterior inferior cerebellar artery: a clinicopathological study of 20 cases. Brain. 1990;113(Pt1):134–155.Google Scholar
  95. 95.
    Amarenco P, Rosingart A, DeWitt LD, Pessin MS Caplan R. Anterior inferior cerebellar infarcts: mechanisms clinical features. Arch Neurol. 1993;50(20): 154–181.PubMedCrossRefGoogle Scholar
  96. 96.
    Nagaratnam N, Mak J, Phan TA, Kalouche H. Sudden permanent hearing loss following anterior inferior cerebellar artery infarction. IJCP. 2002;56:153–154.PubMedGoogle Scholar
  97. 97.
    Erdemoglu AK, Duman T. Superior cerebellar artery territory stroke. Acta Neurol Scand. 1998;98(8):283–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Levine SR, Welch KMA. Superior cerebellar artery infarction and vertebral artery dissection. Stroke. 1988;19:1431–1434.PubMedCrossRefGoogle Scholar
  99. 99.
    Sacco RL, Freddo L, Bello JA, Odel JG Onestie ST, Mohr JP. Wallenberg’s lateral medullary syndrome: Clinical –magnetic resonance imaging correlations. Arch Neurol. 1993; 50(6):609–14.PubMedCrossRefGoogle Scholar
  100. 100.
    Aydogdu I, Ertekin C, Tarlau S, Turman B, Kiylioglu N, Secil Y. Dysphagia in lateral medullary infarction (Wallenberg’s syndrome) Stroke. 2001;32:2081–2087.PubMedCrossRefGoogle Scholar
  101. 101.
    Mendelow AD. Spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991; 54:193–195.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Kim JS, Lee JH, Lee MC. Small lacunar intracerebral haemorrhage. Stroke. 1994;25:1500–1506.PubMedCrossRefGoogle Scholar
  103. 103.
    Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc. 1981;29:151–157.PubMedCrossRefGoogle Scholar
  104. 104.
    Massaro AR, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Price TR, et al. Clinical discrimination of lobar and deep haemorrhages. Neurology. 1991;41:1181–1185.CrossRefGoogle Scholar
  105. 105.
    Kase CS, Williams JP, Wyatte DA, Mohr JP. Lobar intracerebral hematomas: clinical and CT analysis of 22 cases. Neurology. 1982; Oct 32(10): 1146–50.PubMedCrossRefGoogle Scholar
  106. 106.
    Ropper AH, Davis KR. Lobar cerebral haemorrhages: acute clinical syndromes in 26 cases. Ann Neurol. 1980; Aug 8(2):141–7.PubMedCrossRefGoogle Scholar
  107. 107.
    Broderick JP, Brott T,Tomsick T, Huster G, Miller R. The rise of subarachnoid and intracerebral haemorrhages in blacks as compared to whites. NEJM. 1992;326:733–736.PubMedCrossRefGoogle Scholar
  108. 108.
    Vinters HV. Cerebral amyloid angiopathy. In: Barnett HJM, Mohr JP, Stein BM, Yabsu FM. eds Stroke: Pathophysiology, diagnosis and management. 3rf ed. New York; Churchill, Livingstone, 1998.Google Scholar
  109. 109.
    Greenberg SM, Vonsattel J-P G. Diagnosis of cerebral amyloid angiopathy. Stroke. 1997;28:1418–1422.PubMedCrossRefGoogle Scholar
  110. 110.
    Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston Criteria. Curr Athero Rep. 2003;5:60–66.Google Scholar
  111. 111.
    Gunatilleke S. Rapid resolution of symptoms and signs of intracerebral haemorrhage: case report. Br Med J. 1998; 316: 1495–1496.CrossRefGoogle Scholar
  112. 112.
    Tapia JF, Kase CS, Sawyer JP. Hypertensive putaminal haemorrhage presenting as prime motor hemiparesis. Stroke. 1983;14:50–56.CrossRefGoogle Scholar
  113. 113.
    Nagaratnam N, Saravanja D, Chiu K. Putaminal haemorrhage and outcome. Neurorehab Neural Repair.2001;15:Google Scholar
  114. 114.
    EL-Mitwalli A, Malkoff MD. Intracerebral haemorrhage. Internet J Emergency Intensive Care Med. 2001, 5.Google Scholar
  115. 115.
    Caplan LR, Mohr JP, Kase CS. Intracerebral haemorrhage. In Barnett HJM, Mohr JP, Stein BM, and Yatsu F (eds). Stroke pathophysiology, diagnosis and management. New York Churchill Livingstone Chapter 25 Section III Clinical manifestations of stroke. 1998;681–684.Google Scholar
  116. 116.
    Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Havard Cooperative Stroke Registry. Neurology (NY). 1978;28:754.CrossRefGoogle Scholar
  117. 117.
    Arboix A, Rodriquez-Aguilr R, Oliveres M, Comes E, Garcia-Eroles L, Massons J. Thalamic haemorrhage vs internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality. BMC Neurology. 2007;7:32.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Srinivasan A, Goyal M, Al Azri F, Lum C. State of the art imaging of acute stroke. Radiographics. 2006;26 (Suppl 1): S75–95.PubMedCrossRefGoogle Scholar
  119. 119.
    Rowley HA. The four Ps of acute stroke imaging, parenchyma, pipes, perfusion and penumbra. ANJR. Am J Neuroradiol. 2001;22:599–600.PubMedGoogle Scholar
  120. 120.
    Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, et al. Recommendations for imaging of acute ischaemic stroke. Stroke. 2009; 40:3646–3678.PubMedCrossRefGoogle Scholar
  121. 121.
    Ay H, Oliveira-Filho J, Buonanno FS, Ezzeddine M, Schaefer PW, Rordorf G, et al. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke. 1999;30:2644–2650.PubMedCrossRefGoogle Scholar
  122. 122.
    Moulin T, Tatu L, Vuillier F, Cattin F. Brain CT scan for acute cerebral infarction: early sign of ischaemia. Rev Neurol (Paris). 1999;155(9) 647–55.Google Scholar
  123. 123.
    Abdulla H, Boguslawsky R, Poniatowska R. Hyperacute infarction. Early CT findings. Med Sci Monit. 2000;6(5):1027–30.Google Scholar
  124. 124.
    Becker H, Desch H, Hacker H, Penez A. CT fogging effect with ischaemic cerebral infarct. Neuroradiology. 1979;28(4):185–92.CrossRefGoogle Scholar
  125. 125.
    Skriver EB, Olsen TC. The transient disappearance of cerebral infarcts on CT scan, the so-called fogging effect. Neuroradiology. 1981;22(2):61–9.PubMedCrossRefGoogle Scholar
  126. 126.
    The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–1025.CrossRefGoogle Scholar
  127. 127.
    Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD. Acute stroke management in the elderly. Cerebrovasc Dis. 2007;25:304–308.CrossRefGoogle Scholar
  128. 128.
    Gomez-Choco M, Obach V, Urra X, Amaro S, Cervera A, Vargas M, Chamorro A. The response to IV rt-PA in very old stroke patients. Eur J Neurol. 2008;15(3):253–6.PubMedCrossRefGoogle Scholar
  129. 129.
    Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PL, Ringleb PA, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archves. BMJ 2010;341. https://doi.org/10.1136/bmj.c6046.
  130. 130.
    Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al. Predictors of in-hospital mortality in patients with acute ischaemic stroke treated with thrombolytic therapy. JAMA. 2004;292:1831–8.PubMedCrossRefGoogle Scholar
  131. 131.
    Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, et al. Factors associated with inhospital mortality after administration of thrombolysis in acute ischaemic stroke patients: an analysis of the nationwide inpatient sample 1999–2002. Stroke. 2006;37:440–6.PubMedCrossRefGoogle Scholar
  132. 132.
    Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > or= 80 versus <80 years of age –a systematic review across cohort studies. Age Ageing. 206;35:572–80.Google Scholar
  133. 133.
    Power M. An update on thrombolysis for acute ischaemic stroke. ACNR. 2004;4:36–39.Google Scholar
  134. 134.
    Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–282.PubMedCrossRefGoogle Scholar
  135. 135.
    Katzan L, Furlan AJ, Lloyd LE, Franl JI, Harper DL, Hinchey JA, et al. Use of tissue type plasminogen activator of acute ischaemic stroke. The Cleveland area experience. JAMA. 2000;263:1151–58.CrossRefGoogle Scholar
  136. 136.
    Leslie-Mazwi TM, Chandra RV, Sionsen CZ, Yoo AJ. Elderly patients and intra-arterial stroke therapy. Expert Rev Cardiovasc Ther. 2013;11(12)1713–23.PubMedCrossRefGoogle Scholar
  137. 137.
    Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS.. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part 1 trials. Stroke. 2007;38(4):1274–8.PubMedCrossRefGoogle Scholar
  138. 138.
    Fiorella D, Levy EL, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke.2007;38:881–887.PubMedCrossRefGoogle Scholar
  139. 139.
    Subramaniam S, Hilld MD. S. Decompressive hemicraniotomy for malignant middle cerebral artery infarction. The Neurologist. 2009;15:178–184.PubMedCrossRefGoogle Scholar
  140. 140.
    Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R et al. Malignant middle cerebral artery territory infarction: clinical course and clinical signs. Arch Neurol. 1996;53:309–315.PubMedCrossRefGoogle Scholar
  141. 141.
    Schwab S, Steiner T, Aschoff A, Schwb S, Steiner HH, Jansen O, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888–1893.PubMedCrossRefGoogle Scholar
  142. 142.
    Arac A, Blanchard V, Lee M, Steinberg G. Assessment of outcome following decompressive craniotomy for malignant middle cerebral artery infarction in patients older than 60 years. Neurosurg Focus 2009;26(6): E3  https://doi.org/10.3171/2009.3.FOCUS0958.
  143. 143.
    Schneck MJ. Hemicraniotomy for hemispheric infarction and HAMLET study : a sequel is needed. The Lancet Neurology. 2009;8(4):303–304.PubMedCrossRefGoogle Scholar
  144. 144.
    Bhalla A, Wolfe CD, Rudd AG. Management of acute parameters after stroke QJM. 2001;94:167–172.PubMedCrossRefGoogle Scholar
  145. 145.
    Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin. 1992;10(1):167–76.PubMedGoogle Scholar
  146. 146.
    Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17:861–4.PubMedCrossRefGoogle Scholar
  147. 147.
    Sandser EC, Bath PM, Boysen G, Jatuziz D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (CAST):a randomized, placebo-controlled, double-blind trial. Lancet. 2011;377:741–50.CrossRefGoogle Scholar
  148. 148.
    Jeffry I, Saver JL., Kalafut M. Thrombolysis therapy in stroke: Treatment and Medication. e-medicine http://emedicine.medscope.com/article/116080:treatments
  149. 149.
    Ronning OM, Guldvig B. Should stroke victims routinely receive supplemental oxygen? Stroke. 1999;30:2053–2037.CrossRefGoogle Scholar
  150. 150.
    Oppenheimer SM. Neurogenic cardiac effects of cardiovascular disease. Curr Opin in Neurol. 1994;7(1):20–4.CrossRefGoogle Scholar
  151. 151.
    Metawally Y. Cardiac consequences of stroke. http://yassermetwally.com
  152. 152.
    Mayer SA. Recombinant activated Factor VII for acute intracerebral haemorrhage. Stroke. 2007;38:763–767.Google Scholar
  153. 153.
    Wang DZ, Talkad AV. Treatment of intracerebral haemorrhage. What should we do now? Curr Neurol Neurosci Rep. 2009;9(11):13–18.PubMedCrossRefGoogle Scholar
  154. 154.
    Mayer SA, Brun NC, Broderick J ,Davis S, Dringer MN, Skelnick SE, et al. Safety feasibility of recombinant Factor VII for acute intracerebral haemorrhage. Stroke. 2005b; 36: 74–79.PubMedCrossRefGoogle Scholar
  155. 155.
    Barclay L, Vega C. American Heart and American Stroke Associations endorse New Stroke Guidelines. http://cme.medscape.com/viewarticle/511995
  156. 156.
    Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of acute ischaemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167–1174.PubMedGoogle Scholar
  157. 157.
    Broderick JP, Adams HP, Barson W, Feinberg W, Feldman E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral haemorrhage. Stroke. 1999;30:905–912.PubMedCrossRefGoogle Scholar
  158. 158.
    Amar AP. Controversies in the neurosurgical management of cerebellar haemorrhage and infarction. Neurosurg Focus. 2012;32(4)EI  https://doi.org/10.3171/2012.2.FOCUS11369.CrossRefGoogle Scholar
  159. 159.
    Kalra L. Does age affect benefits of stroke unit rehabilitation? Stroke. 1994;25:346–351.PubMedCrossRefGoogle Scholar
  160. 160.
    Kalra L, Dale P,Crome P. Improving stroke rehabilitation: a controlled study. Stroke 1993;24:1462–1467.PubMedCrossRefGoogle Scholar
  161. 161.
    Teasell R, McClure AB. The Principles of Stroke Rehabilitation. http://www.ebrsr.com/-ebrsr/uploads/B_Principles_of_Stroke_Rehabilitation_(Full_Version).pdf. accessed 15.2.2013.
  162. 162.
    Rathore SS, Hinn AR, Cooper LS, Tyroler H, Rosamond WD. Characterization of incidence stroke signs and symptoms: findings from the Atherosclerosis Risk in Communities Study. Stroke. 2002;33:2718–2721.PubMedCrossRefGoogle Scholar
  163. 163.
    Fritz SL, Light KE, Patterson TS, Behrman AZ, Davis SB. Active finger extension predicts outcomes after constraint-induced movement therapy for individuals with hemiparesis after stroke. Stroke 2005;36:1172–1177.PubMedCrossRefGoogle Scholar
  164. 164.
    Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741–754.PubMedCrossRefGoogle Scholar
  165. 165.
    Dobkin B. Neuromedical complications in stroke patients transferred for rehabilitation before and after diagnostic related groups. J Neuro Rehabil. 1987; 1:3–7.Google Scholar
  166. 166.
    Milanod IG. Mechanisms of baclofen action in spasticity. Acta Neurol Scand. 1991;85:305–310CrossRefGoogle Scholar
  167. 167.
    Pedersen E, Arlein-Soborog P, Mai J. The mode of action of the gaba derivative baclofen in human spasticity. Acta Neurol Scand 1974;50:665–85.PubMedCrossRefGoogle Scholar
  168. 168.
    Ketel WB, Kolb ME. Long term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function. Curr Med Res Opin. 1984;9:161–169.PubMedCrossRefGoogle Scholar
  169. 169.
    Gresham GE, Duncan PW, Stason KB, Adams HP, Jr, Adelman AM, Alexander DM, et al. Post stroke rehabilitation Clinical Practice Guidelines. No 16. Rockville, Md: US Department of Health and Human Services, Public Health Services, Aging for Health Care Policy and Research May 1995. AHCPR Publication No. 95–0662.Google Scholar
  170. 170.
    Royal College of Physicians Clinical Guidelines for Stroke 2nd ed. Prepared by Intercollegiate Stroke Working Party. London RCP, 2004.Google Scholar
  171. 171.
    Vuagnat H, Chantraine L. Shoulder pain in hemiplegia revisited: contribution of functional electrical stimulation and other therapies. J Rehabil Med. 2003;35:49–54.PubMedCrossRefGoogle Scholar
  172. 172.
    Paolucci S. Epidemiology and treatment of post stroke depression. Neuropsychiatr Dis Treat. 2008;4(1):145–54.PubMedPubMedCentralCrossRefGoogle Scholar
  173. 173.
    Starkstein SE, Mizrahi R, Power BD. Expert Opin Pharmacother. 2008;9(8):291–8.CrossRefGoogle Scholar
  174. 174.
    Turner-Stokes L, Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2. Treatment alternatives. Clin Rehab. 2002;16(3):248–60.CrossRefGoogle Scholar
  175. 175.
    Aizen E, Shuaev I, Lenger R. Risk factors and characteristics of falls during inpatient rehabilitation of elderly patients. Arch Geront Geriatr. 2007;44:1–12.CrossRefGoogle Scholar
  176. 176.
    Robinson RG. The Clinical Neuropsychiatry of stroke. New York. Cambridge University Press,1998.Google Scholar
  177. 177.
    Shimada K, Robinson RG. Effects of anxiety disorder on impairment and recovering from stroke. J Neuropsychiatry Clin Neuro Sci. 1998;10:34–40.CrossRefGoogle Scholar
  178. 178.
    Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis. 2001; 12(2): 75–81.PubMedCrossRefGoogle Scholar
  179. 179.
    De Groot MH, Phillips ST, Eskes GA. Fatigue associated with stroke and other associated conditions: implications for stroke rehabilitation. Arch Phys Med Rehabil. 2003; 84(10):1714–20.PubMedCrossRefGoogle Scholar
  180. 180.
    Colle F, Bonan I, Gillaz Leman MC, Bradai N, Yalnik K. Fatigue after stroke. Ann Readapt Med Phys. 2006;48(6):272–6.CrossRefGoogle Scholar
  181. 181.
    Park JY, Chun MH, Kang SH, Lee JA, Kim BA, Shin MJ. Functional outcome in post-stroke patients with and without fatigue. Am J Phys Med Rehabil. 2009;88(7):554–8.PubMedCrossRefGoogle Scholar
  182. 182.
    Jaracz K, Mielcarek L, Kozubski W. Clinical and psychological correlations of post-stroke fatigue. Preliminary results. Neuro Neurochir Pol. 2007;41(1):34–43.Google Scholar
  183. 183.
    Nakayama H, Jorgensen H, Raaschou H, Olsen T. Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil.1994;75:394–398.PubMedCrossRefGoogle Scholar
  184. 184.
    Europeans are living longer. Official website of European Union. http://europa.eu/abc/keyfigures/sizeandpopulation/older/index en.htm
  185. 185.
    Di Carlo A, Baldereschi M, Gandolfo C, Candelise L, Ghetti A, Maggi S, et al. Stroke in an elderly population: incidence and impact on survival and daily function> Italian Longitudinal Study on Aging. Cerebrovasc Dis. 2003;16:141–50.PubMedCrossRefGoogle Scholar
  186. 186.
    Marini C Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I, et al. Burden of first-ever ischaemic stroke in the oldest old: evidence from a population-based study. Neurology. 2004;62:77–81.PubMedCrossRefGoogle Scholar
  187. 187.
    Sacco RL. Risk factors outcomes and stroke subtypes for ischaemic stroke. Neurology. 1997;49(suppl4):S39-S44.PubMedCrossRefGoogle Scholar
  188. 188.
    American Stroke Association. Heart Disease and Stroke Statistics-2003. Update, Dallas Texas, 2003.337. Kuller L, Selster R. Cerebrovascular disease: mortality in Maryland. Am J Epidemiol. 1967;86:442–44.Google Scholar
  189. 189.
    Kuller L, Selster R. Cererivascular disease: mortality in Maryland. Am J epidemiol.1967;86:442–44.PubMedCrossRefGoogle Scholar
  190. 190.
    Salonin JT, Puskin B, Tuomilchto J, Homan K. Relationship of blood pressure, serum lipids and cigarette smoking to the risk of cerebral stroke Stroke. 1982;13:327–333.CrossRefGoogle Scholar
  191. 191.
    Kannel WB. Current status of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke. 1971;2:295–318.PubMedCrossRefGoogle Scholar
  192. 192.
    Ostfield AM. A review of stroke epidemiology. In PE Startwell and Nathanson eds. Epidemiologic Reviews. Vol 2 Baltimore. The John Hopkins, University Press.1980;136–152.Google Scholar
  193. 193.
    Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q. Autophagy, proteasomes, lipofuscin, and oxidative stress in the ageing brain. Int J Biochem Cell Biol. 2004;36:2376–2391.PubMedCrossRefGoogle Scholar
  194. 194.
    Kelly KM, Nadon NL, Morrison JH, Tibault O, Barnec A, Blalock EM. The neurobiology of aging. Epilepsy Res 2006; 68 Supl 1:S5-S20.PubMedCrossRefGoogle Scholar
  195. 195.
    Siliman RA, Wagner EH, Fletcher RH. The Social and functional consequences of stroke for elderly patients. Stroke. 1987;18:200–203.CrossRefGoogle Scholar
  196. 196.
    Claesson L, Linden T, Skoog I, Biomstrand C. Cognitive impairment after stroke-impact on activities of daily living and costs of care for elderly people. http://www.researchgate.nt/pubication/8122490_Cognitive_Impai…_Activities_of_Daily_Living_and_Costs_of_Care_for-Elderly_People. Accessed 30 Aprl 2016.
  197. 197.
    Desrosiers J, Bourbonnais D, Noreau L, Rochette A, Bravo G, Bourget A. Participation after stroke compared to normal aging. J Rehabil Med. 2005;37:353–357.PubMedCrossRefGoogle Scholar
  198. 198.
    Garraway WM, Akhtar AJ, Hocky L, Prescott RJ. Management of acute stroke in the elderly: Follow up of a controlled trial. Br Med J. 1980:28:827–82.CrossRefGoogle Scholar
  199. 199.
    Ahlsio B, Britton M, Murray V, Theorell T. Disablement and quality of life after stroke. Stroke. 1954;15:886–890.CrossRefGoogle Scholar
  200. 200.
    Gersham GE, Phillips TF, Wof PA, McNamara PM, Kannel WB, Dawber TR. Epidemiologic profile of long term stroke disability. The Framingham study. Arch Phys Med Rehabil. 1979;60:487–491.Google Scholar
  201. 201.
    Breuer J, Pacon M, Gauthrier A, Brown MM. Stroke and TIA are recognised complications of acute herpes zoster. Neurology 2014;82(3):206–212.Google Scholar
  202. 202.
    Patrick JT, Russell E, Meyer J, Biller J, Saver JL. Cervical (C2) herpes zoster infection followed by pontine infarction. J Neuroimaging. 1995;5(3):192–3.Google Scholar
  203. 203.
    Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis and treatment. Lancet Neurol 2009;8:731–740.Google Scholar
  204. 204.
    Nagel MA, Gilden D. The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep. 2015;15(4):16.  https://doi.org/10.1007/s11910-015-0534-4.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations